{"transactions":[{"id":2064186,"issuer":{"id":11899,"kind":"organization","name":"VIVEVE MEDICAL, INC.","symbol":"VIVE"},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2023-01-05T16:02:45.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the earlier of December 1, 2023 or the closing of a Sale Event (as defined in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan), subject to the reporting person's continuous service to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the earlier of December 1, 2023 or the closing of a Sale Event (as defined in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan), subject to the reporting person's continuous service to the Issuer."}],"balance_after":36000,"derivative":{"underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001437749-23-000480","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879682/000143774923000480/rdgdoc.xml","form_type":"4"}},{"id":2442166,"issuer":{"id":11899,"kind":"organization","name":"VIVEVE MEDICAL, INC.","symbol":"VIVE"},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Purchase)","published_at":"2022-01-06T16:03:19.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan, as amended (the \"2013 Plan\") and received 18,000 non-qualified stock options on January 4, 2022 (the \"Grant Date\"). The non-qualified stock options shall vest and become exercisable in 48 equal monthly installments from the Grant Date."}],"balance_after":18000,"derivative":{"exercise_price":1.26,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001437749-22-000546","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879682/000143774922000546/rdgdoc.xml","form_type":"4"}},{"id":2655259,"issuer":{"id":11899,"kind":"organization","name":"VIVEVE MEDICAL, INC.","symbol":"VIVE"},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Purchase)","published_at":"2021-06-25T16:05:39.000Z","date":"2021-06-23","kind":"grant","acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan (the \"Plan\") and received 39,000 non-qualified stock options on June 23, 2021 (the \"Grant Date\"). The non-qualified stock options shall vest and become exercisable in 48 equal monthly installments from the Grant Date."}],"balance_after":39000,"derivative":{"exercise_price":2.73,"expiration_date":"2031-06-22","underlying":"Common Stock","underlying_shares":39000},"source":{"system":"sec-edgar","filing":"0001437749-21-015656","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879682/000143774921015656/rdgdoc.xml","form_type":"4"}},{"id":2899833,"issuer":{"id":11899,"kind":"organization","name":"VIVEVE MEDICAL, INC.","symbol":"VIVE"},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2021-01-22T19:16:41.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan and received 25,000 RSUs on January 20, 2021 (the \"Grant Date\"). The RSUs vest in full on the second anniversary of the Grant Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan and received 25,000 RSUs on January 20, 2021 (the \"Grant Date\"). The RSUs vest in full on the second anniversary of the Grant Date."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-21-001110","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879682/000143774921001110/rdgdoc.xml","form_type":"4"}},{"id":2997733,"issuer":{"id":11899,"kind":"organization","name":"VIVEVE MEDICAL, INC.","symbol":"VIVE"},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2020-10-30T16:27:48.000Z","date":"2020-10-28","kind":"grant","acquired":true,"shares":330000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in three equal annual installments after October 28, 2020, subject to the Reporting Person's continued service on the Issuer's board of directors through each such vesting date."}],"balance_after":330000,"derivative":{"exercise_price":0.51,"expiration_date":"2030-10-27","underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001437749-20-022112","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879682/000143774920022112/rdgdoc.xml","form_type":"4"}},{"id":3756468,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-11-20T22:48:03.000Z","date":"2018-11-16","kind":"tax_withholding","acquired":false,"shares":11200,"price":1.0673,"value":11953.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, June 2017 and May 2018, pursuant to the Reporting Person's agreement with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 2,257,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell beneficially owns or has a right to acquire 2,538,185 shares of common stock."}],"balance_after":280993,"source":{"system":"sec-edgar","filing":"0001209191-18-059500","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919118059500/doc4.xml","form_type":"4"}},{"id":3766901,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-11-13T22:17:42.000Z","date":"2018-11-08","kind":"sale","acquired":false,"shares":40000,"price":1.27,"value":50800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 2,257,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell beneficially owns or has a right to acquire 2,549,385 shares of common stock."}],"balance_after":292193,"source":{"system":"sec-edgar","filing":"0001209191-18-058330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919118058330/doc4.xml","form_type":"4"}},{"id":3841802,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-16T23:03:53.000Z","date":"2018-08-15","kind":"grant","acquired":true,"shares":675000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the option shares vest and become exercisable on August 15, 2019 and the remaining shares vest in 12 equal quarterly installments thereafter."}],"balance_after":675000,"derivative":{"exercise_price":1.135,"expiration_date":"2028-08-15","underlying":"Common Stock","underlying_shares":675000},"source":{"system":"sec-edgar","filing":"0001209191-18-047204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919118047204/doc4.xml","form_type":"4"}},{"id":3841801,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-08-16T23:03:53.000Z","date":"2018-08-16","kind":"tax_withholding","acquired":false,"shares":11655,"price":1.1075,"value":12907.9125,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, June 2017 and May 2018, pursuant to the Reporting Person's agreement with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 2,257,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell beneficially owns or has a right to acquire 2,589,385 shares of common stock."}],"balance_after":332193,"source":{"system":"sec-edgar","filing":"0001209191-18-047204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919118047204/doc4.xml","form_type":"4"}},{"id":3915495,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-29T21:44:08.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option shares vest and become exercisable over 16 equal quarterly installments measured from May 15, 2018."}],"balance_after":300000,"derivative":{"exercise_price":1.84,"expiration_date":"2028-05-24","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-18-033927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919118033927/doc4.xml","form_type":"4"}},{"id":3915494,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-05-29T21:44:08.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":74380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Annual long-term equity award approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares represent a grant of Restricted Stock Units (\"RSUs\").  The RSUs represent a right to receive shares of the Issuer's common stock, at no additional conversion or exercise price.  The RSUs vest and settle over 16 equal quarterly installments measured from May 15, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number does not include 1,582,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell beneficially owns or has a right to acquire 1,926,040 shares of common stock."}],"balance_after":343848,"source":{"system":"sec-edgar","filing":"0001209191-18-033927","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919118033927/doc4.xml","form_type":"4"}},{"id":3928189,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-05-17T21:42:17.000Z","date":"2018-05-16","kind":"tax_withholding","acquired":false,"shares":8325,"price":1.6621,"value":13836.9825,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016 and June 2017, pursuant to the Reporting Person's agreement with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 1,282,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell beneficially owns or has a right to acquire 1,551,660 shares of common stock."}],"balance_after":269468,"source":{"system":"sec-edgar","filing":"0001209191-18-031111","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919118031111/doc4.xml","form_type":"4"}},{"id":4047630,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-02-20T13:54:42.000Z","date":"2018-02-16","kind":"tax_withholding","acquired":false,"shares":9420,"price":1.0855,"value":10225.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016 and June 2017, pursuant to the Reporting Person's agreement with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 1,282,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell beneficially owns or has a right to acquire 1,559,985 shares of common stock."}],"balance_after":277793,"source":{"system":"sec-edgar","filing":"0001209191-18-011103","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919118011103/doc4.xml","form_type":"4"}},{"id":4160500,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-11-17T00:49:27.000Z","date":"2017-11-16","kind":"tax_withholding","acquired":false,"shares":5860,"price":1.4702,"value":8615.372,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016 and June 2017, pursuant to the Reporting Person's agreement with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 1,282,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell beneficially owns or has a right to acquire 1,569,405 shares of common stock."}],"balance_after":287213,"source":{"system":"sec-edgar","filing":"0001209191-17-061328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117061328/doc4.xml","form_type":"4"}},{"id":4230754,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-08-17T20:52:40.000Z","date":"2017-08-16","kind":"tax_withholding","acquired":false,"shares":6115,"price":2.06,"value":12596.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016 and June 2017, pursuant to the Reporting Person's agreement with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 1,282,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell beneficially owns or has a right to acquire 1,575,265 shares of common stock."}],"balance_after":293073,"source":{"system":"sec-edgar","filing":"0001209191-17-049428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117049428/doc4.xml","form_type":"4"}},{"id":4270165,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-06-29T21:17:05.000Z","date":"2017-06-27","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Annual long-term equity award approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares represent a grant of Restricted Stock Units (\"RSUs\").  The RSUs represent a right to receive shares of the Issuer's common stock, at no additional conversion or exercise price.  The RSUs vest and settle over 16 equal quarterly installments measured from May 15, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number does not include 1,282,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell beneficially owns or has a right to acquire 1,581,380 shares of common stock."}],"balance_after":299188,"source":{"system":"sec-edgar","filing":"0001209191-17-042355","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117042355/doc4.xml","form_type":"4"}},{"id":4315794,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-05-17T23:05:20.000Z","date":"2017-05-16","kind":"tax_withholding","acquired":false,"shares":1167,"price":2.8621,"value":3340.0707,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, pursuant to the Reporting Person's agreement with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 1,282,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell continues to beneficially own or have a right to acquire 1,381,380 shares of common stock."}],"balance_after":99188,"source":{"system":"sec-edgar","filing":"0001209191-17-033413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117033413/doc4.xml","form_type":"4"}},{"id":4328280,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-05-09T22:06:12.000Z","date":"2017-03-18","kind":"gift","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents charitable contributions by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 1,282,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell continues to beneficially own or have a right to acquire 1,382,547 shares of common stock."}],"balance_after":100355,"source":{"system":"sec-edgar","filing":"0001209191-17-031052","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117031052/doc5.xml","form_type":"5"}},{"id":4436158,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-02-21T23:02:56.000Z","date":"2017-02-16","kind":"tax_withholding","acquired":false,"shares":1390,"price":2.95,"value":4100.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, pursuant to the Reporting Person's agreement with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 1,282,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell continues to beneficially own or have a right to acquire 1,397,547 shares of common stock."}],"balance_after":115355,"source":{"system":"sec-edgar","filing":"0001209191-17-012857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117012857/doc4.xml","form_type":"4"}},{"id":4548736,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":120951,"kind":"person","name":"Presnell Sharon Collins","position":1,"cik":"0001536585","reported_name":"Presnell Sharon Collins","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-11-18T22:10:09.000Z","date":"2016-11-16","kind":"tax_withholding","acquired":false,"shares":1210,"price":3.2594,"value":3943.874,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, pursuant to the Reporting Person's agreement with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 1,282,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell continues to beneficially own or have a right to acquire 1,398,937 shares of common stock."}],"balance_after":116745,"source":{"system":"sec-edgar","filing":"0001209191-16-151276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919116151276/doc4.xml","form_type":"4"}}]}